Dengue NS1 Antigen, IgM/IgG Antibody Dual

Zazzabin Dengue cuta ce mai saurin kamuwa da cuta ta hanyar cizon sauro mata masu ɗauke da kwayar cutar dengue (DENV), tare da saurin yaɗuwa, yawan kamuwa da cuta, kamuwa da cuta mai yawa, da yawan mace-mace a lokuta masu tsanani.^.

Kimanin mutane miliyan 390 a duniya ke kamuwa da cutar zazzabin Dengue kowace shekara, inda mutane miliyan 96 ke kamuwa da cutar a cikin kasashe sama da 120, mafi muni a Afirka, Amurka, Kudu maso Gabashin Asiya da Yammacin Pacific.Yayin da dumamar yanayi ke ƙaruwa, zazzabin dengue a yanzu yana yaduwa zuwa yankuna masu sanyi da sanyi da kuma tudu masu tsayi, kuma yawan ƙwayoyin serotypes na canzawa.A cikin 'yan shekarun nan, yanayin cutar zazzabin dengue ya fi tsanani a yankin Kudancin Pacific, Afirka, Amurka ta Kudu, Kudancin Asiya da kudu maso gabashin Asiya, kuma yana nuna nau'in nau'in watsawa na serotype, yanayin tsayi, yanayi, yawan mace-mace da kuma yawan mace-mace. yawan cututtuka.

Alkaluman hukumar ta WHO a watan Agustan 2019 sun nuna cewa akwai kimanin mutane 200,000 da suka kamu da zazzabin dengue da kuma mutuwar mutane 958 a Philippines.Malesiya ta tara fiye da 85,000 cututtukan dengue a tsakiyar watan Agusta 2019, yayin da Vietnam ta tara shari'o'i 88,000.Idan aka kwatanta da lokaci guda a cikin 2018, adadin ya ƙaru fiye da ninki biyu a cikin ƙasashen biyu.WHO ta dauki zazzabin dengue a matsayin babbar matsalar lafiyar jama'a.

Wannan samfurin sigar sauri ce, akan-site kuma ingantaccen kayan ganowa don ƙwayar dengue NS1 antigen da IgM/IgG antibody.Specific IgM antibody yana nuna cewa akwai kamuwa da cuta kwanan nan, amma gwajin IgM mara kyau baya tabbatar da cewa jikin bai kamu da cutar ba.Hakanan wajibi ne a gano takamaiman ƙwayoyin rigakafi na IgG tare da tsawon rabin rayuwa da mafi girman abun ciki don tabbatar da ganewar asali.Bugu da ƙari, bayan da jiki ya kamu da cutar, NS1 antigen ya fara bayyana, don haka gano kwayar cutar dengue a lokaci guda NS1 antigen da takamaiman IgM da IgG antibodies zasu iya gano maganin rigakafi na jiki ga wani takamaiman pathogen, kuma wannan antigen-antibody hade da ganowa. kit na iya yin saurin ganewar asali da bincike a farkon matakin kamuwa da cutar dengue, kamuwa da cuta na farko da na sakandare ko kamuwa da cutar dengue da yawa, rage lokacin taga kuma inganta ƙimar ganowa.